HealthcareServices

Anaphylaxis Market Forecast 2026–2035: How to Leverage Market Growth

February 19, 2026February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the anaphylaxis market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Anaphylaxis Market expected to reach by 2030?

The anaphylaxis market has experienced substantial growth in recent years. This market is projected to expand from $3.5 billion in 2025 to $3.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. Historically, this expansion has been driven by factors such as an increasing incidence of food and drug allergies, enhanced diagnosis of allergic conditions, the widespread availability of emergency epinephrine treatments, growing public health awareness, and the adoption of standardized treatment guidelines.

The anaphylaxis market is projected for robust expansion in the coming years, with its size anticipated to reach $5.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This anticipated growth during the forecast period is attributed to several factors, including improved access to emergency allergy care, a rising demand for portable treatment solutions, the broadening of allergy specialty services, a greater emphasis on patient education programs, and increased investment in allergy management infrastructure. Key trends expected over this period involve the wider availability of epinephrine auto-injectors, heightened public awareness concerning severe allergic reactions, a stronger focus on emergency preparedness, advancements in allergy diagnosis and monitoring, and an intensified commitment to rapid response protocols.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

What Drivers Are Driving Adoption Within The Anaphylaxis Market?

The increasing occurrence of food allergies is anticipated to drive the expansion of the anaphylaxis market in the future. Food allergies involve the immune system reacting to specific foods, leading to symptoms from minor to critical, such as potentially fatal anaphylaxis. This increase in food allergy prevalence stems from elements like evolving eating patterns, environmental factors, and enhanced recognition and diagnosis. Treatment for anaphylaxis offers vital, life-saving support to individuals with food allergies by quickly alleviating severe allergic responses, mitigating symptoms like swelling, respiratory distress, and decreased blood pressure. It ensures prompt stabilization, averting potentially fatal consequences, and equips patients to respond swiftly to future allergic episodes. For example, data from September 2024, supplied by the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, indicates that approximately 220 million individuals worldwide suffer from food allergies. It’s possible for one food item to contain several allergens, and people can be allergic to numerous food types. Furthermore, in May 2024, the Patterns and Prevalence of Adult Food Allergy (PAFA) report, issued by the Food Standards Agency (FSA), a UK-based non-ministerial department, stated that more than 30% of adults experienced adverse reactions linked to food, with clinical evaluations confirming food allergies in roughly 6% of UK adults, which amounts to about 2.4 million individuals. Consequently, the increasing incidence of food allergies is propelling the expansion of the anaphylaxis market.

How Is The Anaphylaxis Market Organized Into Various Segments?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

Which Trends Are Guiding The Evolution Of The Anaphylaxis Market?

Leading companies within the anaphylaxis market are concentrating on developing advanced epinephrine nasal sprays, designed to enable quicker, more efficient drug delivery during emergencies. An epinephrine nasal spray is a medical device that administers epinephrine (adrenaline) through the nasal passages to treat severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced the approval of Neffy (epinephrine nasal spray) by the Food and Drug Administration, a US-based government agency, establishing it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, potentially offering a more accessible option for emergency treatment. Neffy aims to enhance patient compliance by eliminating the need for needles while delivering rapid, life-saving epinephrine during severe allergic reactions.

Who Are The Prominent Global Companies Shaping The Anaphylaxis Market Landscape?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anaphylaxis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp

Browse Through More Reports Similar to the Global Anaphylaxis Market 2026, By The Business Research Company

Allergic Rhinitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

Inhalable Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795